Rudolf Hoellrich, MD
Orthopaedic Surgery · Eugene, ORNPI 1013917285
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,400 of the $3,605 with a category attached, or 66.6%. Steelhead Surgical Inc accounts for 71.2% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2021 at $1,423 and has fallen 80.3% since, to $281 in 2025.
Across 23 payments — averaging $156.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Steelhead Surgical Inc$3K
- Arthrex$301
- Stryker$223
- Anika Therapeutics, Inc.$140
- Innovation Technologies Inc$120
- Shoulder Innovations, Inc.$73
- plus $183 from 7 others
Across 33 payments — averaging $9687.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medical Device Business Services, Inc.$320K
What the payments were for
- Food & beverage$1,20533%
- Education$2,40067%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Steelhead Surgical Inc | 4 | $2,565 |
| Arthrex | 3 | $301 |
| Stryker | 2 | $223 |
| Anika Therapeutics, Inc. | 2 | $140 |
| Innovation Technologies Inc | 2 | $120 |
| Shoulder Innovations, Inc. | 2 | $73 |
| Johnson & Johnson | 2 | $44 |
| Medical Device Business Services, Inc. | 1 | $36 |
| Vericel Corporation | 1 | $32 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Sonex Health, Inc. | 1 | $19 |
| Sanara Medtech Inc. | 1 | $17 |
| Medacta USA, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,605 in reported general payments places this provider in the 55th percentile of 228 orthopaedic surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 34 | $250 |
| Ondansetron OdtOndansetron | 22 | $122 |
| Cyclobenzaprine Hcl | 20 | $96 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Eugene
- Daniel FitzpatrickEugene$481K
- Monica ZilkoskiEugene$17K
- Lucas KorcekEugene$9K
- Patrick DenardMedford$11.5M
- James BallardOregon City$2.4M
- Steven MadeyLake Oswego$1.2M
- Michelle WelbornPortland$364K
- Elizabeth LiebermanPortland$353K
- Jonathan SalesPortland$303K
- James HaydenPortland$264K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.